European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading

MT Newswires Live
Aug 21

European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.74% to 1,979.62 on the S&P Europe Select ADR Index, which is up 0.55% for the week so far.

From continental Europe, the gainers were led by accommodations booking site trivago (TRVG) and biotech firm BioNTech (BNTX), which advanced 7.2% and 6.2%, respectively. They were followed by lender Banco Santander (SAN) and furniture maker Natuzzi (NTZ), which rose 2.9% and 1.7%, respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and oil and gas company Eni (E), which dropped 4.2% and 1.2%, respectively. They were followed by medical device maker EDAP TMS (FOCL) and healthcare tech company Royal Philips (PHG), which were off 1.1% and 0.4%, respectively.

The gainers from the UK were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical firm Bicycle Therapeutics (BCYC), which climbed 6.6% and 4.3%, respectively. They were followed by mining company BHP Group (BHP) and lender Lloyds Banking Group (LYG), which were up 2.9% and 2.1%, respectively.

The decliners from the UK and Ireland were led by telecommunications operator Vodafone Group (VOD) and biotech firm Autolus Therapeutics (AUTL), which lost 0.5% and 0.4% respectively. They were followed by alcoholic beverage company Diageo (DEO) and hospitality company Intercontinental Hotels Group (IHG), which were down 0.3% each.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10